Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Spinocerebellar Degenerations × vicriviroc × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Spinocerebellar Degenerations 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 5 Nivolumab 2 Bevacizumab 2 vicriviroc 1 trifluridine tipiracil drug combination 1 spartalizumab 1 relatlimab 1 regorafenib 1 epacadostat 1 copanlisib 1 binimetinib 1 atezolizumab 1 Tiragolumab 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 E7046 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631407 2024-11-21

MK-7690-046

Merck Sharp & Dohme LLC

Phase 2 Completed

41 enrolled 20 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡